Zobrazeno 1 - 3
of 3
pro vyhledávání: '"CD8 Antigens/immunology"'
Autor:
Denise Nardelli-Haefliger, Ilaria Lucca, Massimo Valerio, Patrice Jichlinski, Sonia-Christina Rodrigues-Dias, Laurent Derré, Rodolfo Burruni, Florence Dartiguenave, Thomas Tawadros, Valérie Cesson, Perrine Bohner, Mathieu F. Chevalier
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2019, 10, ⟨10.3389/fimmu.2019.00622⟩
Frontiers in Immunology, Vol 10 (2019)
Frontiers in immunology, vol. 10, pp. 622
Frontiers in Immunology, Frontiers, 2019, 10, ⟨10.3389/fimmu.2019.00622⟩
Frontiers in Immunology, Vol 10 (2019)
Frontiers in immunology, vol. 10, pp. 622
The immune system plays a central role in cancer development, showing both anti-tumor and pro-tumor activities depending on the immune cell subsets and the disease context. While CD8 T cells are associated with a favorable outcome in most cancers, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f34716cc65e1b6de45583df3a05f67e
https://hal.archives-ouvertes.fr/hal-03031633/document
https://hal.archives-ouvertes.fr/hal-03031633/document
Autor:
Dejan Pavlovic, Peter In 'T Veld, Marika Bogdani, Miriam Pipeleers-Marichal, Daniel Pipeleers
Publikováno v:
Xenotransplantation. 13:415-422
Background: Pre-natal porcine endocrine islet cell grafts were recently shown to contain immature beta cells with a marked potential for growth and differentiation following transplantation, and hence for a progressive and long-term correction of dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92504a26262f7e9528d328a31b725fe
https://doi.org/10.1111/j.1399-3089.2006.00328.x
https://doi.org/10.1111/j.1399-3089.2006.00328.x
Autor:
Emilie Bialecki, François Trottein, Luis J. Cruz, Josette Fontaine, Reem Ghinnagow, Elodie Macho-Fernandez, Benoît Frisch, Christelle Faveeuw
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Immunotherapy aiming at enhancing innate and acquired host immunity is a promising approach for cancer treatment. The invariant NKT (iNKT) cell ligand α-galactosylceramide (α-GalCer) holds great promise in cancer therapy, although several concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d564a81d30efc92538f3b7fbb6a0b5
https://www.hal.inserm.fr/inserm-02436034
https://www.hal.inserm.fr/inserm-02436034